Chemotherapy of atherosclerosis

Area of Science:

• Cardiovascular Research
• Cellular Metabolism
• Vascular Biology

Background:

• Atherosclerosis is increasingly recognized as both preventable and reversible.
• Primary prevention via risk factor elimination is challenging in modern society.
• Focus is shifting towards combined risk factor management and direct arterial wall intervention.

Purpose of the Study:

• To investigate the role of endothelial cell metabolism in atherosclerosis.
• To explore therapeutic strategies targeting endothelial dysfunction.
• To evaluate compounds beneficial for endothelial cell metabolism and atherosclerosis regression.

Main Methods:

• Review of clinical and experimental studies on atherosclerosis.
• Analysis of energy and cyclic nucleotide metabolism in endothelial cells.
• Documentation of clinical effects of compounds acting on endothelial metabolism.

Main Results:

• Endothelial cell dysfunction is a key factor in atherosclerosis initiation, progression, and regression.
• Several compounds demonstrate beneficial effects on endothelial cell metabolism.
• Clinical studies have documented favorable outcomes associated with these compounds.

Conclusions:

• A combined approach of risk factor reduction and direct arterial wall treatment is crucial for atherosclerosis prevention and regression.
• Targeting endothelial cell metabolism presents a promising therapeutic avenue.
• Further research into chemotherapy for endotheliopathy and atherosclerosis is warranted.